Geode Capital Management, LLC Cytosorbents Corp Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 438,297 shares of CTSO stock, worth $376,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares

438,297

Previous 364,920 20.11%

Holding current value

$376,935

Previous $405,000 2.72%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.86 - $1.07 $63,104 - $78,513	73,377 Added 20.11%	438,297 $416,000
Q3 2023 Nov 13, 2023	SELL	$1.86 - $4.03 $12,625 - $27,355	-6,788 Reduced 1.83%	364,920 $686,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $1.63 $3,284 - $5,198	3,189 Added 0.87%	371,708 $576,000
Q3 2022 Nov 14, 2022	BUY	$1.39 - $2.46 $1,263 - $2,236	909 Added 0.25%	368,519 $501,000
Q2 2022 Aug 12, 2022	SELL	$1.76 - $3.22 $589,784 - $1.08 Million	-335,105 Reduced 47.69%	367,610 $805,000

Q1 2022 May 13, 2022	BUY	$2.88 - $4.23 $25,344 - $37,224	8,800 Added 1.27%	702,715 $2.24 Million
Q4 2021 Feb 11, 2022	SELL	$4.05 - $8.11 $13,162 - $26,357	-3,250 Reduced 0.47%	693,915 $2.91 Million
Q3 2021 Nov 12, 2021	BUY	$7.0 - $9.71 $23,324 - $32,353	3,332 Added 0.48%	697,165 $5.66 Million
Q2 2021 Aug 13, 2021	BUY	$7.55 - $9.42 $274,623 - $342,643	36,374 Added 5.53%	693,833 $5.24 Million
Q1 2021 May 12, 2021	BUY	$8.23 - $11.48 $732,897 - $1.02 Million	89,052 Added 15.67%	657,459 $5.71 Million
Q4 2020 Feb 12, 2021	BUY	$7.65 - $8.98 $317,872 - $373,136	41,552 Added 7.89%	568,407 $4.53 Million
Q3 2020 Nov 13, 2020	BUY	$7.37 - $11.54 $509,252 - $797,390	69,098 Added 15.09%	526,855 $4.2 Million
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $223,473 - $376,845	35,585 Added 8.43%	457,757 $4.53 Million
Q1 2020 May 14, 2020	BUY	$3.77 - $7.73 $235,700 - $483,279	62,520 Added 17.38%	422,172 $3.26 Million
Q4 2019 Feb 13, 2020	BUY	$3.61 - $5.22 $24,876 - $35,971	6,891 Added 1.95%	359,652 $1.38 Million
Q3 2019 Nov 12, 2019	BUY	$4.33 - $7.63 $25,642 - $45,184	5,922 Added 1.71%	352,761 $1.77 Million
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $144,767 - $190,252	24,454 Added 7.59%	346,839 $2.29 Million
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $142,449 - $178,792	20,887 Added 6.93%	322,385 $2.44 Million
Q4 2018 Feb 13, 2019	BUY	$7.05 - $12.64 $117,586 - $210,822	16,679 Added 5.86%	301,498 $2.44 Million
Q3 2018 Nov 13, 2018	BUY	$10.95 - $14.8 $499,538 - $675,176	45,620 Added 19.07%	284,819 $3.67 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $650,787 - $1.16 Million	94,317 Added 65.1%	239,199 $2.73 Million
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $74,146 - $92,823	11,320 Added 8.48%	144,882 $1.02 Million
Q4 2017 Feb 13, 2018	BUY	$5.9 - $7.05 $37,978 - $45,380	6,437 Added 5.06%	133,562 $868,000
Q2 2017 Aug 14, 2017	BUY	N/A	127,125	127,125 $546,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Cytosorbents Corp Transaction History